NCT02092389View on ClinicalTrials.gov

Fecal Calprotectin Levels, Quality of Life, and Workability in Patients Suffering From Ulcerative Colitis Under Adalimumab Therapy - AdaProQuo

TerminatedOBSERVATIONAL

Enrollment

10

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

March 31, 2016

Conditions

Moderate to Severe Ulcerative Colitis

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AbbVie

INDUSTRY